WHO consults on public disclosure of clinical trial results
This article was originally published in SRA
Executive Summary
The World Health Organization has become the latest entity to take forward ongoing efforts for greater transparency around the conduct of clinical trials by launching a 30-day public consultation on this topic1,2. The public consultation exercise ends on 15 November and will culminate in the WHO issuing an official statement on the public disclosure of clinical trial results.
You may also be interested in...
Medical Research Funders To Implement WHO’s Trial Disclosure Standard
The World Health Organization’s 2015 standard that specifies strict timelines for reporting clinical trial results is to be implemented by major medical research funders and NGOs in a year’s time.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.